Status:
COMPLETED
Swedish Macrolane Registry
Lead Sponsor:
Galderma R&D
Conditions:
Breast Augmentation
Eligibility:
FEMALE
Brief Summary
A Registry to monitor long term safety in female subjects after treatment with Macrolane VRF20 and/or MacrolaneT VRF30 in the breasts.
Eligibility Criteria
Inclusion
- Females previously treated with Macrolane VRF in the breasts
- Females continuously being treated with Macrolane VRF in the breasts, initial treatment or re-treatment.
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT01145235
Start Date
April 1 2010
End Date
January 1 2019
Last Update
August 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Per Hedén
Stockholm, Sweden